Remove Nurses Remove Pharmacy Remove Regulations
article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

Food and Drug Administrations (FDA) regulations on good clinical practice, which are based on ethical standards outlined in frameworks such as the Belmont Report and the Declaration of Helsinki. Advarra ensures that clinical trials comply with the U.S.

article thumbnail

Hospitals: Do You Know Where Your Controlled Substances Are?

FDA Law Blog: Biosimilars

But there has been a recent string of large civil monetary settlements, some in the millions of dollars, to resolve allegations that hospitals’ non-compliance with the federal Controlled Substances Act (“CSA”) and DEA regulations allowed employees to divert staggering quantities of controlled substances.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Items Auditors Look for When Reviewing an Investigator Site File

Advarra

In some countries, local regulations may indicate the sub-investigators need to sign as well. Both the medical licenses and nurse licenses need to be up to date. Pharmacy File Ensure inventory records are up to date. Determine if there is a separate delegation log in pharmacy or included in ISF.

article thumbnail

Beginner’s Guide to Human Research Protection Programs

Advarra

Together, these three principles form the foundation upon which HRPPs were established and provide the basis for laws, regulations, guidelines, and policies governing human subjects research. They must ensure research is conducted in compliance with the protocol and applicable policies and regulations.

article thumbnail

9 Healthcare Trends For 2024

Perficient: Drug Development

And the cycle deepens and worsens with every newly departing nurse or physician — many of whom can’t or won’t be replaced due to budget freezes or an inadequate supply of potential candidates. It also presents significant risks to patient safety, the quality of care at affected organizations, and the sustainability of those HCOs.

article thumbnail

DEA’s Expected Guidance: It Should Reduce Current “Pain” at the (Intrathecal Pain) Pump Dispensing Process and Improve Therapeutic Outcomes

FDA Law Blog: Biosimilars

The CSA and regulations promulgated by DEA are intended to reduce the potential for diversion and abuse and ensure that controlled substances are dispensed and delivered to patients for a legitimate medical purpose. 2] Why is this an issue? the “ultimate user”). the “ultimate user”).

Nurses 98
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Indeed, even the weird alternatives the plaintiff advocated, such as “point of sale” signs and DTC advertising (assuming these were Prop 65 remedies at all), were still FDA-regulated labeling. Alcozar didn’t buy it, since the particular regulations did not even apply to the clinics and health care providers that plaintiffs were targeting.